ACOT12 and metabolic dysfunction-associated steatotic liver disease: Among key regulators in acetyl-CoA metabolism, the expression level of ACOT12 was the most significantly altered in both steatosis and NASH compared to normal liver tissue, and its expression gradually changed during the progression of NAFLD (Fig. 1b and Supplementary Fig. 1).